
Amanda L. Aguirre
Examiner (ID: 17942, Phone: (571)272-5592 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626 |
| Total Applications | 850 |
| Issued Applications | 613 |
| Pending Applications | 94 |
| Abandoned Applications | 188 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17443601
[patent_doc_number] => 20220064106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => NITRIC OXIDE DONORS
[patent_app_type] => utility
[patent_app_number] => 17/474637
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474637
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474637 | NITRIC OXIDE DONORS | Sep 13, 2021 | Abandoned |
Array
(
[id] => 18207155
[patent_doc_number] => 20230053411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES
[patent_app_type] => utility
[patent_app_number] => 17/470459
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 145440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 311
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470459
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470459 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | Sep 8, 2021 | Abandoned |
Array
(
[id] => 17460212
[patent_doc_number] => 20220073517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => BLUE THERMALLY ACTIVATED DELAYED FLUORESCENT EMITTERS AND HOSTS BASED ON FUNCTIONALIZED IMIDAZOLYL GROUPS
[patent_app_type] => utility
[patent_app_number] => 17/470092
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 377
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470092
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470092 | BLUE THERMALLY ACTIVATED DELAYED FLUORESCENT EMITTERS AND HOSTS BASED ON FUNCTIONALIZED IMIDAZOLYL GROUPS | Sep 8, 2021 | Pending |
Array
(
[id] => 17314386
[patent_doc_number] => 20210403434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => METABOLICALLY STABLE 5-HMF DERIVATIVES FOR THE TREATMENT OF HYPOXIA
[patent_app_type] => utility
[patent_app_number] => 17/468035
[patent_app_country] => US
[patent_app_date] => 2021-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17468035
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/468035 | Metabolically stable 5-HMF derivatives for the treatment of hypoxia | Sep 6, 2021 | Issued |
Array
(
[id] => 18692427
[patent_doc_number] => 20230322661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => Synthesis of N,N-Branched Sulfamoyl Fluoride Compounds Using Bismuth Trifluoride
[patent_app_type] => utility
[patent_app_number] => 18/021751
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021751
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021751 | Synthesis of N,N-Branched Sulfamoyl Fluoride Compounds Using Bismuth Trifluoride | Aug 18, 2021 | Pending |
Array
(
[id] => 19441177
[patent_doc_number] => 12091417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => 7-ethyl-10-hydroxycamptothecin derivatives for use in the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 17/398016
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4437
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398016
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/398016 | 7-ethyl-10-hydroxycamptothecin derivatives for use in the treatment of cancer | Aug 9, 2021 | Issued |
Array
(
[id] => 17369833
[patent_doc_number] => 20220024885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/393834
[patent_app_country] => US
[patent_app_date] => 2021-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17393834
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/393834 | METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF | Aug 3, 2021 | Pending |
Array
(
[id] => 17243611
[patent_doc_number] => 20210363354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => Method for Improving Alkali Resistance and Oxidation Resistance of Benzothiazole Disperse Dye
[patent_app_type] => utility
[patent_app_number] => 17/392463
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392463
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392463 | Method for improving alkali resistance and oxidation resistance of benzothiazole disperse dye | Aug 2, 2021 | Issued |
Array
(
[id] => 17243610
[patent_doc_number] => 20210363353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => Method for Improving Alkali Resistance and Oxidation Resistance of Benzisothiazole Disperse Dye
[patent_app_type] => utility
[patent_app_number] => 17/392478
[patent_app_country] => US
[patent_app_date] => 2021-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17392478
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/392478 | Method for Improving Alkali Resistance and Oxidation Resistance of Benzisothiazole Disperse Dye | Aug 2, 2021 | Abandoned |
Array
(
[id] => 18939558
[patent_doc_number] => 20240034697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-01
[patent_title] => CORE-SHELL COMPOSITE CATALYST, PREPARATION METHOD FOR SAME, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/018390
[patent_app_country] => US
[patent_app_date] => 2021-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018390
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/018390 | CORE-SHELL COMPOSITE CATALYST, PREPARATION METHOD FOR SAME, AND USE THEREOF | Jul 26, 2021 | Pending |
Array
(
[id] => 17369867
[patent_doc_number] => 20220024919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/376823
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 916
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17376823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/376823 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | Jul 14, 2021 | Abandoned |
Array
(
[id] => 18391543
[patent_doc_number] => 20230159761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => METHOD FOR CHLORINATING BLUE ANTHRONE, VIOLANTHRONE OR ISOVIOLANTRONE
[patent_app_type] => utility
[patent_app_number] => 17/630532
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630532
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630532 | Method for chlorinating blue anthrone, violanthrone or isoviolantrone | Jul 11, 2021 | Issued |
Array
(
[id] => 17369906
[patent_doc_number] => 20220024958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING SAME
[patent_app_type] => utility
[patent_app_number] => 17/305557
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1293
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305557
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305557 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING SAME | Jul 8, 2021 | Pending |
Array
(
[id] => 17369906
[patent_doc_number] => 20220024958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING SAME
[patent_app_type] => utility
[patent_app_number] => 17/305557
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1293
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305557
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305557 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING SAME | Jul 8, 2021 | Pending |
Array
(
[id] => 18869771
[patent_doc_number] => 11857551
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-01-02
[patent_title] => Methods for the prevention and treatment of hearing loss
[patent_app_type] => utility
[patent_app_number] => 17/371847
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 50
[patent_no_of_words] => 7377
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371847
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371847 | Methods for the prevention and treatment of hearing loss | Jul 8, 2021 | Issued |
Array
(
[id] => 18610808
[patent_doc_number] => 20230277538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => THERAPEUTICS FOR THE TREATMENT OF FSHD
[patent_app_type] => utility
[patent_app_number] => 18/011583
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011583
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011583 | THERAPEUTICS FOR THE TREATMENT OF FSHD | Jun 22, 2021 | Pending |
Array
(
[id] => 19731089
[patent_doc_number] => 12209080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-28
[patent_title] => Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/348482
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 53
[patent_no_of_words] => 18628
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348482 | Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof | Jun 14, 2021 | Issued |
Array
(
[id] => 17480470
[patent_doc_number] => 20220087974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => METHOD AGAINST CORONAVIRUS INFECTION WITH COUMARIN-DERIVED COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/333266
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17333266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/333266 | METHOD AGAINST CORONAVIRUS INFECTION WITH COUMARIN-DERIVED COMPOUND | May 27, 2021 | Abandoned |
Array
(
[id] => 17355240
[patent_doc_number] => 20220016036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/333224
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17333224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/333224 | Sustained release dosage forms for a JAK1 inhibitor | May 27, 2021 | Issued |
Array
(
[id] => 17170313
[patent_doc_number] => 20210323983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => STABLE SILYLATING REAGENTS
[patent_app_type] => utility
[patent_app_number] => 17/332394
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17332394
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/332394 | STABLE SILYLATING REAGENTS | May 26, 2021 | Abandoned |